The 2011 Harvard Cambridge Scholars

Four new graduates head back to school—in the other Cambridge

Four members of the class of 2011 have won Harvard Cambridge Scholarships to study at Cambridge University during the 2010-2011 academic year. English concentrator Molly Fitzpatrick, of Winthrop House and River Edge, New Jersey, will be the Lionel de Jersey Scholar at Emmanuel College; social studies concentrator Jacob McNulty, of Dunster House and Short Hills, New Jersey, will be the John Eliot Scholar at Jesus College; chemical and physical biology concentrator James Pelletier, of Adams House and Attleboro, Massachusetts, will be the Governor William Shirley Scholar at Pembroke College; and applied mathematics concentrator Jackson Salovaara, of Pforzheimer House and Bernardsville, New Jersey, will be the Charles Henry Fiske III Scholar at Trinity College.

Related topics

You might also like

The play Spare Parts is a contemporary fable about the quest to live forever.

David Battat promotes alumni engagement.

Derek Bok donated his car for a good cause.

Most popular

The University will compensate families of those whose remains were sold and establish a scholarship to honor anatomical donors.

The program will focus on the U.S. Congress and the separation of powers in its first year.

The 1884 Cannibalism-at-Sea Case That Still Has Harvard Talking

The Queen v. Dudley and Stephens changed the course of legal history. Here’s why it’s been fodder for countless classroom debates.

Explore More From Current Issue

Decorative wrought iron gate framed by leafy branches, captured in sepia tones.

Former Indiana University president Thomas Ehrlich looks back on curriculum, co-education, and other major trends.

A smiling elderly man in glasses sits comfortably in a striped armchair.

Plus, veteran higher education leader Thomas Ehrlich reflects on university curricula for his 70th reunion

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.